Brokerages expect Kala Pharmaceuticals Inc (NASDAQ:KALA) to report $960,000.00 in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Kala Pharmaceuticals’ earnings, with estimates ranging from $500,000.00 to $1.72 million. The firm is scheduled to announce its next quarterly earnings results on Thursday, May 9th. According to Zacks, […]
